JP2021535080A5 - - Google Patents
Info
- Publication number
- JP2021535080A5 JP2021535080A5 JP2020571384A JP2020571384A JP2021535080A5 JP 2021535080 A5 JP2021535080 A5 JP 2021535080A5 JP 2020571384 A JP2020571384 A JP 2020571384A JP 2020571384 A JP2020571384 A JP 2020571384A JP 2021535080 A5 JP2021535080 A5 JP 2021535080A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- compound
- formulated
- immune response
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023077029A JP2023109826A (ja) | 2018-07-02 | 2023-05-09 | 新規免疫調節小分子 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862693023P | 2018-07-02 | 2018-07-02 | |
| US62/693,023 | 2018-07-02 | ||
| PCT/US2019/040313 WO2020010090A1 (en) | 2018-07-02 | 2019-07-02 | Novel immunodulating small molecules |
| US16/460,211 US11364253B2 (en) | 2018-07-02 | 2019-07-02 | Immunodulating small molecules |
| US16/460,211 | 2019-07-02 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023077029A Division JP2023109826A (ja) | 2018-07-02 | 2023-05-09 | 新規免疫調節小分子 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021535080A JP2021535080A (ja) | 2021-12-16 |
| JP2021535080A5 true JP2021535080A5 (https=) | 2022-03-16 |
| JP7728560B2 JP7728560B2 (ja) | 2025-08-25 |
Family
ID=69060166
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020571384A Active JP7728560B2 (ja) | 2018-07-02 | 2019-07-02 | 新規免疫調節小分子 |
| JP2023077029A Pending JP2023109826A (ja) | 2018-07-02 | 2023-05-09 | 新規免疫調節小分子 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023077029A Pending JP2023109826A (ja) | 2018-07-02 | 2023-05-09 | 新規免疫調節小分子 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11364253B2 (https=) |
| JP (2) | JP7728560B2 (https=) |
| KR (1) | KR20210027381A (https=) |
| AU (1) | AU2019297321B2 (https=) |
| BR (1) | BR112020026989A2 (https=) |
| CA (1) | CA3103503A1 (https=) |
| MX (1) | MX2020014087A (https=) |
| WO (1) | WO2020010090A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220143059A1 (en) * | 2016-03-30 | 2022-05-12 | Ayuvis Research, Inc. | Compositions and therapeutic methods |
| US12594286B2 (en) | 2018-07-02 | 2026-04-07 | Ayuvis Research, Inc. | Immunodulating small molecules |
| WO2022169855A1 (en) * | 2021-02-04 | 2022-08-11 | Ayuvis Research, Inc. | Chitin analogs for the treatment of kidney diseases |
| US12440471B2 (en) * | 2021-07-30 | 2025-10-14 | Ayuvis Research, Inc. | Compositions and methods for the treatment of bronchopulmonary dysplasia (BPD) and BPD-associated pulmonary hypertension |
| WO2023086877A1 (en) * | 2021-11-12 | 2023-05-19 | Ayuvis Research, Inc. | Novel compositions and therapeutic methods |
| EP4531867A1 (en) * | 2022-05-25 | 2025-04-09 | Ayuvis Research, Inc. | Novel immunodulating small molecules |
| WO2024220628A1 (en) * | 2023-04-18 | 2024-10-24 | The Regents Of The University Of Colorado, A Body Corporate | Target for combatting the foreign body response to implantable biomaterials |
| US20250332183A1 (en) * | 2024-04-30 | 2025-10-30 | Ayuvis Research, Inc. | Compositions and methods for the stimulation of intermediate macrophages and treatments therewith |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3931319A (en) | 1974-10-29 | 1976-01-06 | Millmaster Onyx Corporation | Capped polymers |
| US4027020A (en) | 1974-10-29 | 1977-05-31 | Millmaster Onyx Corporation | Randomly terminated capped polymers |
| US4525346A (en) | 1981-09-28 | 1985-06-25 | Alcon Laboratories, Inc. | Aqueous antimicrobial ophthalmic solutions |
| US4407791A (en) | 1981-09-28 | 1983-10-04 | Alcon Laboratories, Inc. | Ophthalmic solutions |
| US4404365A (en) * | 1981-12-28 | 1983-09-13 | American Cyanamid Company | Modulators of the complement system |
| US4836986A (en) | 1984-09-28 | 1989-06-06 | Bausch & Lomb Incorporated | Disinfecting and preserving systems and methods of use |
| US4621075A (en) | 1984-11-28 | 1986-11-04 | The Procter & Gamble Company | Gel-form topical antibiotic compositions |
| US4806352A (en) | 1986-04-15 | 1989-02-21 | Ribi Immunochem Research Inc. | Immunological lipid emulsion adjuvant |
| EP0273512B1 (en) | 1986-12-19 | 1991-02-27 | Duphar International Research B.V | Stabilised adjuvant suspension comprising dimethyl dioctadecyl ammonium bromide |
| ES2052685T3 (es) | 1987-03-17 | 1994-07-16 | Akzo Nv | Metodo para producir un adyuvante libre. |
| US5037647A (en) | 1988-09-15 | 1991-08-06 | Alcon Laboratories, Inc. | Aqueous antimicrobial opthalmic solutions comprised of quaternary ammonium compound, citric acid, citrate and sodium chloride |
| US5145643A (en) | 1990-01-05 | 1992-09-08 | Allergan, Inc. | Nonoxidative ophthalmic compositions and methods for preserving and using same |
| US5300287A (en) | 1992-11-04 | 1994-04-05 | Alcon Laboratories, Inc. | Polymeric antimicrobials and their use in pharmaceutical compositions |
| CN1053193C (zh) * | 1993-11-15 | 2000-06-07 | 吴羽化学工业株式会社 | 七叶亭衍生物和其制造方法与用途及其医药组合物 |
| AU7484198A (en) | 1997-05-12 | 1998-12-08 | Sage Pharmaceuticals, Inc. | Topical spray for burn treatment and anti-infection |
| JP2004505925A (ja) * | 2000-08-10 | 2004-02-26 | オーシャン、ニュートリッション、カナダ、リミテッド | 免疫調節特性を示すクロレラ調製物 |
| US20050255048A1 (en) | 2004-05-15 | 2005-11-17 | Collegium Pharmaceutical, Inc. | Sprayable formulations for the treatment of acute inflammatory skin conditions |
| WO2008054892A2 (en) * | 2006-06-16 | 2008-05-08 | Florida Atlantic University | Chitin micro-particles as an adjuvant |
| WO2016077567A1 (en) * | 2014-11-12 | 2016-05-19 | Tumorend, Llc | Compositions, methods and treatments for inhibiting cell adhesion and virus binding and penetration |
| JP2019513137A (ja) | 2016-03-30 | 2019-05-23 | アユヴィス リサーチ インク．Ａｙｕｖｉｓ Ｒｅｓｅａｒｃｈ， Ｉｎｃ． | 新規組成物及び治療方法 |
-
2019
- 2019-07-02 KR KR1020217001831A patent/KR20210027381A/ko active Pending
- 2019-07-02 AU AU2019297321A patent/AU2019297321B2/en active Active
- 2019-07-02 MX MX2020014087A patent/MX2020014087A/es unknown
- 2019-07-02 WO PCT/US2019/040313 patent/WO2020010090A1/en not_active Ceased
- 2019-07-02 BR BR112020026989-1A patent/BR112020026989A2/pt unknown
- 2019-07-02 US US16/460,211 patent/US11364253B2/en active Active
- 2019-07-02 CA CA3103503A patent/CA3103503A1/en active Pending
- 2019-07-02 JP JP2020571384A patent/JP7728560B2/ja active Active
-
2023
- 2023-05-09 JP JP2023077029A patent/JP2023109826A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021535080A5 (https=) | ||
| JP2023109826A5 (https=) | ||
| EP2482816B1 (en) | Topical compositions of naltrexone for treating skin conditions | |
| AU717201B2 (en) | Use of bis-1,2,4-triazoles for the manufacture of a medicament for the treatment of cancers | |
| WO2020102804A3 (en) | Pharmaceutical combination for treatment of cancer | |
| JP2014515373A5 (https=) | ||
| EP0820281B1 (en) | A pharmaceutical composition containing n-chlorophenylcarbamates and n-chlorophenylthiocarbamates for inhibiting the growth of viruses | |
| JP2014516942A5 (https=) | ||
| JP2017513824A5 (https=) | ||
| JP2010527940A5 (https=) | ||
| CN1323660C (zh) | 治疗病毒性皮肤和肿瘤疾病的药物 | |
| KR20100100953A (ko) | 항종양 요법 또는 면역억제 요법에 의해 유발되는 점막염의 치료를 위한 제제 | |
| AU2007291517A1 (en) | Pharmaceutical compositions for the treatment of fungal infections | |
| WO1996040122A1 (en) | Use of benzimidazoles for the manufacture of a medicament for the treatment of leukemia | |
| GB2591937A (en) | Methods of using a phenoxypropylamine compound to treat pain | |
| MY144580A (en) | Substituted 1,4-di-piperidin-4-yl-piperazine derivative combined with an opioid analgesic and their use for the treatment of pain and side-effects associated with opioid-based treatments | |
| MX2024006270A (es) | Nueva composicion farmaceutica oral y regimen de dosificacion para la terapia de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| Saul et al. | Itraconazole in common dermatophyte infections of the skin: fixed treatment schedules | |
| IL319025A (en) | Methods for treating or preventing endometriosis | |
| US20100168238A1 (en) | Pharmaceutical composition containing phloroglucinol and paracetamol | |
| JP2003519683A5 (https=) | ||
| EP3337512A1 (en) | A topical antiviral composition | |
| RU2003126176A (ru) | Кислотно-аддитивные соли тербинафина и яблочной кислоты | |
| CA2489705A1 (en) | Use of amide derivative of ge 2270 factor a3 for the treatment of acne | |
| PH12022553502A1 (en) | Topical formulations of (1s)-1-phenyl-2-pyridin-2-ylethanamine |